AX PHARMACEUTICAL CORP- lufenuron powder

Nazione: Stati Uniti

Lingua: inglese

Fonte: NLM (National Library of Medicine)

Principio attivo:

LUFENURON (UNII: 1R754M4918) (LUFENURON - UNII:1R754M4918)

Commercializzato da:

AX Pharmaceutical Corp

Via di somministrazione:

NOT APPLICABLE

Stato dell'autorizzazione:

Bulk Ingredient For Animal Drug Compounding

Scheda tecnica

AX PHARMACEUTICAL CORP- LUFENURON POWDER
AX PHARMACEUTICAL CORP
----------
AX PHARMACEUTICAL CORP
lufenuron powder
AX Pharmaceutical Corp
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 2157-58 8
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
LUFENURO N (UNII: 1R754M49 18 ) (LUFENURON - UNII:1R754M49 18 )
LUFENURON
22.77 kg in 23 kg
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
WATER (UNII: 0 59 QF0 KO0 R)
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 2157-58 8 -0 1
23 kg in 1 DRUM
0 5/23/20 18
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
bulk ingredient fo r animal drug
c o mpo unding
0 5/23/20 18
LABELER -
AX Pharmaceutical Corp (202924858)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
AX Pharmaceutical Co rp
20 29 248 58
repack(6 2157-58 8 ) , relabel(6 2157-58 8 )
Revised: 5/2018